水仙花提取物。通过NRF2途径减轻uvb诱导的HaCaT细胞氧化损伤。

IF 4.8 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Pharmaceutical Biology Pub Date : 2025-12-01 Epub Date: 2025-08-07 DOI:10.1080/13880209.2025.2540348
Xu Zhu, Zhongyi Chen, Bin Deng, Chunhao Yang, Fengkun Xiao
{"title":"水仙花提取物。通过NRF2途径减轻uvb诱导的HaCaT细胞氧化损伤。","authors":"Xu Zhu, Zhongyi Chen, Bin Deng, Chunhao Yang, Fengkun Xiao","doi":"10.1080/13880209.2025.2540348","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong><i>Buddleja officinalis</i> Maxim., a prominent medicinal plant from the Scrophulariaceae family, is extensively distributed throught China, Korea, Vietnam, and Myanmar. This phytotherapeutic agent has demonstrated significant clinical efficacy in treating various ophthalmic disorders, such as xerophthalmia, infectious conjunctivitis, keratopathies, corneal ulcerations, and neuropathic ocular pain.</p><p><strong>Objective: </strong>To explore the potential photoprotective effects of <i>Buddleja officinalis</i> Maxim. extract (BOE) against UVB-induced oxidative damage in human immortalized keratinocytes.</p><p><strong>Materials and methods: </strong>In this study, we analyzed BOE components using HPLC and evaluated scavenging activities against 2, 2'-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azinobis 3-ethylbenzothiazoline 6-sulfonate (ABTS), and Superoxide anion (O<sub>2</sub><sup>·-</sup>) through biochemical assays. Cell viability was assessed with cell counting kit-8 assay (CCK-8) and lactate dehydrogenase (LDH) kits, intracellular reactive oxygen species (ROS) levels were quantified by flow cytometry, and cellular antioxidant enzyme activities were determined using commercial assay kits. To investigate specific antioxidant pathways, qPCR and Western blot analyses were performed.</p><p><strong>Results: </strong>The biochemical assays demonstrated that BOE possesses significant antioxidant activity. Additionally, BOE significantly alleviated the adverse effects of UVB exposure (30 mJ/cm<sup>2</sup>), which were characterized by decreased cell viability, elevated LDH activity, increased intracellular ROS levels, reduced activities of superoxide dismutase (SOD), decreased the levels of reduced glutathione (GSH), and increased Malondialdehyde (MDA) content. And the BOE modulates the antioxidant defense pathway by upregulating the mRNA and protein expression levels of nuclear factor erythroid 2-related factor 2(NRF2), heme oxygenase-1 (HO-1), and NAD(P)H: quinone oxidoreductase 1 (NQO1).</p><p><strong>Discussion and conclusions: </strong>Our findings indicate that the photoprotective efficacy of BOE makes it a promising candidate for incorporation as a natural component in pharmaceutical and cosmetic formulations.</p>","PeriodicalId":19942,"journal":{"name":"Pharmaceutical Biology","volume":"63 1","pages":"567-581"},"PeriodicalIF":4.8000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333036/pdf/","citationCount":"0","resultStr":"{\"title\":\"The extract of <i>buddleja officinalis</i> maxim. alleviates UVB-induced oxidative damage <i>via</i> the NRF2 pathway in HaCaT cells.\",\"authors\":\"Xu Zhu, Zhongyi Chen, Bin Deng, Chunhao Yang, Fengkun Xiao\",\"doi\":\"10.1080/13880209.2025.2540348\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong><i>Buddleja officinalis</i> Maxim., a prominent medicinal plant from the Scrophulariaceae family, is extensively distributed throught China, Korea, Vietnam, and Myanmar. This phytotherapeutic agent has demonstrated significant clinical efficacy in treating various ophthalmic disorders, such as xerophthalmia, infectious conjunctivitis, keratopathies, corneal ulcerations, and neuropathic ocular pain.</p><p><strong>Objective: </strong>To explore the potential photoprotective effects of <i>Buddleja officinalis</i> Maxim. extract (BOE) against UVB-induced oxidative damage in human immortalized keratinocytes.</p><p><strong>Materials and methods: </strong>In this study, we analyzed BOE components using HPLC and evaluated scavenging activities against 2, 2'-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azinobis 3-ethylbenzothiazoline 6-sulfonate (ABTS), and Superoxide anion (O<sub>2</sub><sup>·-</sup>) through biochemical assays. Cell viability was assessed with cell counting kit-8 assay (CCK-8) and lactate dehydrogenase (LDH) kits, intracellular reactive oxygen species (ROS) levels were quantified by flow cytometry, and cellular antioxidant enzyme activities were determined using commercial assay kits. To investigate specific antioxidant pathways, qPCR and Western blot analyses were performed.</p><p><strong>Results: </strong>The biochemical assays demonstrated that BOE possesses significant antioxidant activity. Additionally, BOE significantly alleviated the adverse effects of UVB exposure (30 mJ/cm<sup>2</sup>), which were characterized by decreased cell viability, elevated LDH activity, increased intracellular ROS levels, reduced activities of superoxide dismutase (SOD), decreased the levels of reduced glutathione (GSH), and increased Malondialdehyde (MDA) content. And the BOE modulates the antioxidant defense pathway by upregulating the mRNA and protein expression levels of nuclear factor erythroid 2-related factor 2(NRF2), heme oxygenase-1 (HO-1), and NAD(P)H: quinone oxidoreductase 1 (NQO1).</p><p><strong>Discussion and conclusions: </strong>Our findings indicate that the photoprotective efficacy of BOE makes it a promising candidate for incorporation as a natural component in pharmaceutical and cosmetic formulations.</p>\",\"PeriodicalId\":19942,\"journal\":{\"name\":\"Pharmaceutical Biology\",\"volume\":\"63 1\",\"pages\":\"567-581\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333036/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical Biology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13880209.2025.2540348\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13880209.2025.2540348","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:佛家箴言。是一种著名的玄参科药用植物,广泛分布于中国、朝鲜、越南和缅甸。这种植物治疗剂在治疗各种眼部疾病,如干眼症、感染性结膜炎、角膜病、角膜溃疡和神经性眼痛等方面显示出显著的临床疗效。目的:探讨大佛的潜在光保护作用。提取物(BOE)对uvb诱导的人永生化角质形成细胞氧化损伤的影响。材料与方法:本研究采用高效液相色谱法分析了BOE各组分对2,2′-二苯基-1-吡啶肼(DPPH)、2,2-氮唑比斯- 3-乙基苯并噻唑啉- 6-磺酸盐(ABTS)和超氧阴离子(O2·-)的清除活性。采用细胞计数试剂盒-8 (CCK-8)和乳酸脱氢酶(LDH)试剂盒评估细胞活力,采用流式细胞术定量细胞内活性氧(ROS)水平,采用商业检测试剂盒测定细胞抗氧化酶活性。为了研究特定的抗氧化途径,进行了qPCR和Western blot分析。结果:生化实验表明京东方具有明显的抗氧化活性。此外,BOE显著缓解了UVB暴露(30 mJ/cm2)的不良反应,其特征是细胞活力降低,LDH活性升高,细胞内ROS水平升高,超氧化物歧化酶(SOD)活性降低,还原谷胱甘肽(GSH)水平降低,丙二醛(MDA)含量升高。BOE通过上调核因子-红系2相关因子2(NRF2)、血红素加氧酶-1 (HO-1)和醌氧化还原酶1 (NQO1) mRNA和蛋白表达水平,调控抗氧化防御通路。讨论和结论:我们的研究结果表明,京东方的光保护作用使其成为药物和化妆品配方中有希望的天然成分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The extract of <i>buddleja officinalis</i> maxim. alleviates UVB-induced oxidative damage <i>via</i> the NRF2 pathway in HaCaT cells.

The extract of <i>buddleja officinalis</i> maxim. alleviates UVB-induced oxidative damage <i>via</i> the NRF2 pathway in HaCaT cells.

The extract of <i>buddleja officinalis</i> maxim. alleviates UVB-induced oxidative damage <i>via</i> the NRF2 pathway in HaCaT cells.

The extract of buddleja officinalis maxim. alleviates UVB-induced oxidative damage via the NRF2 pathway in HaCaT cells.

Context: Buddleja officinalis Maxim., a prominent medicinal plant from the Scrophulariaceae family, is extensively distributed throught China, Korea, Vietnam, and Myanmar. This phytotherapeutic agent has demonstrated significant clinical efficacy in treating various ophthalmic disorders, such as xerophthalmia, infectious conjunctivitis, keratopathies, corneal ulcerations, and neuropathic ocular pain.

Objective: To explore the potential photoprotective effects of Buddleja officinalis Maxim. extract (BOE) against UVB-induced oxidative damage in human immortalized keratinocytes.

Materials and methods: In this study, we analyzed BOE components using HPLC and evaluated scavenging activities against 2, 2'-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azinobis 3-ethylbenzothiazoline 6-sulfonate (ABTS), and Superoxide anion (O2·-) through biochemical assays. Cell viability was assessed with cell counting kit-8 assay (CCK-8) and lactate dehydrogenase (LDH) kits, intracellular reactive oxygen species (ROS) levels were quantified by flow cytometry, and cellular antioxidant enzyme activities were determined using commercial assay kits. To investigate specific antioxidant pathways, qPCR and Western blot analyses were performed.

Results: The biochemical assays demonstrated that BOE possesses significant antioxidant activity. Additionally, BOE significantly alleviated the adverse effects of UVB exposure (30 mJ/cm2), which were characterized by decreased cell viability, elevated LDH activity, increased intracellular ROS levels, reduced activities of superoxide dismutase (SOD), decreased the levels of reduced glutathione (GSH), and increased Malondialdehyde (MDA) content. And the BOE modulates the antioxidant defense pathway by upregulating the mRNA and protein expression levels of nuclear factor erythroid 2-related factor 2(NRF2), heme oxygenase-1 (HO-1), and NAD(P)H: quinone oxidoreductase 1 (NQO1).

Discussion and conclusions: Our findings indicate that the photoprotective efficacy of BOE makes it a promising candidate for incorporation as a natural component in pharmaceutical and cosmetic formulations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pharmaceutical Biology
Pharmaceutical Biology 医学-药学
CiteScore
6.70
自引率
2.60%
发文量
191
审稿时长
1 months
期刊介绍: Pharmaceutical Biology will publish manuscripts describing the discovery, methods for discovery, description, analysis characterization, and production/isolation (including sources and surveys) of biologically-active chemicals or other substances, drugs, pharmaceutical products, or preparations utilized in systems of traditional medicine. Topics may generally encompass any facet of natural product research related to pharmaceutical biology. Papers dealing with agents or topics related to natural product drugs are also appropriate (e.g., semi-synthetic derivatives). Manuscripts will be published as reviews, perspectives, regular research articles, and short communications. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信